Moderna stock jumps 8% on momentum despite no new news or sector support
Moderna's stock surged 8% in a single day despite no new announcements, regulatory decisions, or clinical trial updates to justify the move. This rally comes after a 143% gain over the past month, largely driven by positive results from its personali...
